Publications en collaboration avec des chercheurs de University of Szeged (15)

2024

  1. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

2023

  1. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10

2022

  1. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

    Frontiers in Oncology, Vol. 12

  2. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

    Blood, Vol. 140, Núm. 26, pp. 2773-2787

  3. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  4. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

    JAMA Dermatology, Vol. 158, Núm. 5, pp. 561-572

2021

  1. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey

    Clinical Nutrition ESPEN, Vol. 45, pp. 433-441

  2. Pregnancy outcomes in women after arterial switch operation for transposition of the great arteries: Results from ropac (registry of pregnancy and cardiac disease) of the european society of cardiology eurobservational research programme

    Journal of the American Heart Association, Vol. 10, Núm. 1, pp. 1-11

2020

  1. Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey

    Clinical Nutrition, Vol. 39, Núm. 2, pp. 585-591

2015

  1. Normal reference values of left ventricular strain using three-dimensional speckle tracking echocardiography: Results from amulticentre study

    European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 4, pp. 410-416

2014

  1. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: Results of the PROTECTION AMI randomized controlled trial

    European Heart Journal, Vol. 35, Núm. 37, pp. 2516-2523

  2. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 16, Núm. 3

2012

  1. Further Evidence of Subphenotype Association with Systemic Lupus Erythematosus Susceptibility Loci: A European Cases Only Study

    PLoS ONE, Vol. 7, Núm. 9

  2. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

2009

  1. Replication of recently identified systemic lupus erythematosus genetic associations: A case-control study

    Arthritis Research and Therapy, Vol. 11, Núm. 3